Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells.

MLA

Nkongolo, Shirin, et al. “Longitudinal Liver Sampling in Patients with Chronic Hepatitis B Starting Antiviral Therapy Reveals Hepatotoxic CD8+ T Cells.” The Journal of Clinical Investigation, vol. 133, no. 1, Jan. 2023. EBSCOhost, https://doi.org/10.1172/JCI158903.

APA

Nkongolo, S., Mahamed, D., Kuipery, A., Sanchez Vasquez, J. D., Kim, S. C., Mehrotra, A., Patel, A., Hu, C., McGilvray, I., Feld, J. J., Fung, S., Chen, D., Wallin, J. J., Gaggar, A., Janssen, H. L., & Gehring, A. J. (2023). Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells. The Journal of Clinical Investigation, 133(1). https://doi.org/10.1172/JCI158903

Chicago

Nkongolo, Shirin, Deeqa Mahamed, Adrian Kuipery, Juan D Sanchez Vasquez, Samuel C Kim, Aman Mehrotra, Anjali Patel, et al. 2023. “Longitudinal Liver Sampling in Patients with Chronic Hepatitis B Starting Antiviral Therapy Reveals Hepatotoxic CD8+ T Cells.” The Journal of Clinical Investigation 133 (1). doi:10.1172/JCI158903.